For reasons that remain unclear, mutations in the PRKAA2 gene (encoding AMPK-α2) are particularly frequent in melanoma and non-melanoma skin cancer — the top six human cancer genome studies that detected the most frequent PRKAA2 mutations, in which the frequency varied from 8% to 23% of cases, all involved skin cancer [30]. This evidence concerns the gene PRKAA2 and skin cancer.